Masami Kawamura

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of Resistance to Targeted Therapy.

ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of Resistance to Targeted Therapy.

Journal: Cancer research
Published: September 18, 2023

Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8+ T cells against tumor.

Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8+ T cells against tumor.

Journal: Journal for immunotherapy of cancer
Published: May 26, 2023

Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II Study.

Augmenting Granzyme B-Expressing NK Cells by Invariant NKT Ligand-Loaded APCs in Patients with Postoperative Early Stage Non-Small Cell Lung Cancer: Results of a Randomized Phase II Study.

Journal: ImmunoHorizons
Published: December 06, 2022

Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML.

Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML.

Journal: Molecular therapy oncolytics
Published: March 23, 2022

A single immunization with cellular vaccine confers dual protection against SARS-CoV-2 and cancer.

A single immunization with cellular vaccine confers dual protection against SARS-CoV-2 and cancer.

Journal: Cancer science
Published: February 02, 2022

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY-ESO-1 antigen to dendritic cells in situ.

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY-ESO-1 antigen to dendritic cells in situ.

Journal: Cancer science
Published: September 07, 2021

Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN.

Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN.

Journal: Frontiers in immunology
Published: November 18, 2018

Optimal therapeutic strategy using antigen-containing liposomes selectively delivered to antigen-presenting cells.

Optimal therapeutic strategy using antigen-containing liposomes selectively delivered to antigen-presenting cells.

Journal: Cancer science
Published: November 07, 2018

Eomes transcription factor is required for the development and differentiation of invariant NKT cells.

Eomes transcription factor is required for the development and differentiation of invariant NKT cells.

Journal: Communications biology
Published: August 23, 2018

In vivo dendritic cell targeting cellular vaccine induces CD4+ Tfh cell-dependent antibody against influenza virus.

In vivo dendritic cell targeting cellular vaccine induces CD4+ Tfh cell-dependent antibody against influenza virus.

Journal: Scientific reports
Published: April 19, 2016

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells.

Transfer of mRNA Encoding Invariant NKT Cell Receptors Imparts Glycolipid Specific Responses to T Cells and γδT Cells.

Journal: PloS one
Published: March 03, 2015

Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength.

Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 31, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026